| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Reynoso Jamie L. | CEO, Medicare Advantage | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso | 16 Sep 2025 | 0001839066 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLOV | Class A Common Stock | Tax liability | $238,813 | -85,596 | -2.9% | $2.79 | 2,887,905 | 30 Jun 2025 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | This Form 4/A is being filed to solely to correct that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below. |
| F2 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 1/3 of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025. |
| F3 | Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2025. |